Return
Developing a better flu vaccine
DOI:10.1016/s1473-3099(26)00467-6.png)
Abstract
En
Journal
IF:
31
Papers:
8.0K
Citations:
4.0W
Organization
Cited Papers
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older
VACCINE
IF3.5
Immunogenicity and safety of higher-dose cell-based adjuvanted quadrivalent influenza vaccines: Combined results of randomised, controlled dose-finding and dose-confirmation studies
Vaccine
IF3.5
Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis
VACCINES
IF3.4
Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact
Vaccine
IF0
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic
Vaccine
IF0
no more

